Assessment of a new immunoassay for serological confirmation and discrimination of human T-cell lymphotropic virus infections

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 1, 1998, Pages 45-49

  Zrein, Maan ^a   Louwagie, Joost ^a   Boeykens, Hilde ^a   Govers, Loeki ^a   Hendrickx, Greet ^a   Bosman, Fons ^a   Sablon, Erwin ^a   Demarquilly, Catherine ^b   Boniface, Michel ^b   Saman, Eric ^b  

^a INNOGENETICS   (Belgium)

^b UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; PRIORITY JOURNAL; VIRUS DETECTION;

EID: 0031907652     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.1.45-49.1998     Document Type: Article

References (32)

1. Banki, K., J. Maceda, E. Hurley, E. Ablonczy, D. H. Mattson, L. Szegedy, C. Hung, and A. Perl. 1992. Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-I gag-reactive autoantibodies. Proc. Natl. Acad. Sci. USA 89:1939-1943.
2. Biggar, R. J., J. E. Neequaye, A. R. Neequaye, G. A. Ankra-Badu, P. H. Levine, A. Manns, M. Taylor, J. Drummond, and D. Waters. 1993. The prevalence of antibodies to the human T lymphotropic virus (HTLV) in Ghana, West Africa. AIDS Res. Hum. Retroviruses 9:505-511.
3. Brookes, S. M., Y. A. Pandolfino, T. J. Mitchell, P. J. Venables, W. G. Shattles, D. A. Clark, A. Entwistle, and R. N. Maini. 1992. The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br. J. Rheumatol. 31:735-742.
4. Centers for Disease Control and Prevention. 1993. False-positive serologic tests for human T-cell lymphotropic virus type I among blood donors following influenza vaccination. 1992. JAMA 269:2076-2078.
5. Chen, Y. M., X. Q. Zhang, C. E. Dahl, K. P. Samuel, R. T. Schooley, M. Essex, and T. S. Papas. 1991. Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses. J. Immunol. 147: 2368-2376.
6. Chironna, M., M. Quarto, C. Germinario, and A. Fontana. 1994. Modified Western blot with recombinant antigens for serological differentiation between HTLV-I and HTLV-II. New Microbiol. 17:177-185.
7. Ferrante, P., M. Seresella, C. E. Cocuzza, D. Caputo, E. Cattaneo, G. Achilli, and C. L. Cazzullo. 1990. HTLV-I antibodies in multiple sclerosis and other neurological diseases. Acta Neurol. (Naples) 12:95-99.
8. Garin, B., S. Gosselin, G. de-Thé, and A. Gessain. 1994. HTLV-I/II infection in a high viral endemic area of Zaire, Central Africa: comparative evaluation of serology, PCR, and significance of indeterminate Western blot pattern. J. Med. Virol. 44:104-109.
9. Hadlock, K. G., C. J. Goh, P. A. Bradshaw, S. Perkins, J. Lo, J. E. Kaplan, R. Khabbaz, and S. K. Foung. 1995. Delineation of an immunodominant and human T-cell lymphotropic virus (HTLV)-specific epitope within the HTLV-I transmembrane glycoprotein. Blood 86:1392-1399.
10. Horal, P., W. W. Hall, B. Svennerholm, J. Lycke, S. Jeansson, L. Rymo, M. H. Kaplan, and A. Vahlne. 1991. Identification of type-specific linear epitopes in the glycoproteins gp45 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides. Proc. Natl. Acad. Sci. USA 88:5754-5758.
11. Ida, H., A. Kurata, K. Eguchi, A. Kawakami, K. Migita, T. Fukuda, T. Nakamura, Y. Kusumoto, J. A. Berzofsky, and S. Nagataki. 1991. Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals. J. Clin. Immunol. 11:143-151.
12. Kaplan, M. H. 1993. Human retroviruses and neoplastic disease. Clin. Infect. Dis. 17(Suppl. 2):S400-S406.
13. Khabbaz, R. F., W. Heneine, A. Grindon, T. M, Hartley, G. Shulman, and J. Kaplan. 1992. Indeterminate HTLV scrologic results in U.S. blood donors: are they due to HTLV-I or HTLV-II? J. Acquired Immune Defic. Syndr. 5:400-404.
14. Lal, K. B., S. K. Brodine, J. E. Coligan, and C. R. Roberts. 1991. Differential antibody responsiveness to p19 gag results in serological discrimination between human T lymphotropic virus type I and type II. J. Med. Virol. 35:232-236.
15. Lal, R. B., D. L. Rudolph, K. P. Griffis, K. Kitamura, M. Honda, J. E. Coligan, and T. M. Folks. 1991. Characterization of immunodominant epitopes of gag and pol gene-encoded proteins of human T-cell lymphotropic virus type I. J. Virol. 65:1870-1876.
16. Lal, R. B., D. L. Rudolph, J. E. Coligan, S. K. Brodine, and C. R. Roberts. 1992. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II. Blood 80:544-550.
17. Lal, R. B., and K. P. Griffis. 1991. Predictive B-and T-cell linear epitopes in structural proteins of HTLV-I, HTLV-II, and STLV-I. AIDS Res. Hum. Retroviruses 7:663-670.
18. Lipka, J. J., K. K. Young, S. Y. Kwok, G. R. Reyes, J. J. Sninsky, and S. K. Foung. 1991. Significance of human T-lymphotropie virus type I indeterminant serological findings among healthy individuals. Vox Sang. 61:171-176.
19. Madeleine, M. M., S. Z. Wiktor, J. J. Goedert, A. Manns, P. H. Levine, R. J. Biggar, and W. A. Blattner. 1993. HTLV-I and HTLV-II world-wide distribution: reanalysis of 4,832 immunoblot results. Int. J. Cancer 54:255-260.
20. Mayer, V., and P. Ebbesen. 1991. HTLV-I virus in Europeans: the continuous spread. A meta-analysis. Acta Virol. 35:472-495.
21. Palker, T. J., E. R. Riggs, D. E. Spragion, A. J. Muir, R. M. Scearce, R. R. Randall, M. W. McAdams, A. McKnight, P. R. Clapham, R. A. Weiss, and B. F. Haynes. 1992. Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropie virus type I and II gp46 envelope glycoproteins. J. Virol. 66:5879-5889.
22. Perron, H., C. Geny, O. Genoulaz, J. Pellat, J. Perret, and J. M. Seigneurin. 1991. Antibody to reverse transcriptase of human retroviruses in multiple sclerosis. Acta Neurol. Scand. 84:507-513.
23. Porter, K. R., R. L. Anthony, A. Solihin, and C. G. Hayes. 1995. Mapping of a human T-lymphotropic virus type I gag protein epitope that cross-reacts with anti-Plasmodium falciparum antibodies. J. Med. Virol. 45:469-474.
24. Re, M. C., G. Furlini, E. Ramazzotti, M. Vignoli, G. Zauli, S. Lolli, P. Monari, D. Belletti, A. Nanetti, M. La-Placa. 1992. Absence of HTLV-I/II infection in blood donors with positive and inconclusive HTLV-1/II serology. Microbiologica 15:329-336.
25. Sabino, E., and M. Zrein. Unpublished data.
26. Sato, A., Y. Isaka, F. Morita, A. Ishii, Y. Goto, J. Imai, H. Igarashi, O. Yoshie, and Y. Hinuma. 1992. Human sera from varicella-zoster virus (VZV) infections cross-react with human T cell leukaemia virus type I (HTLV-1): common epitopes in VZV gene 22 protein and HTLV-I p19 gag protein. J. Gen. Virol. 73(Pt. 11):2969-2973.
27. Soriano, V., M. Gutierrez, O. Aguilera, A. de-la-Rua, and J. Gonzalez-Lahoz. 1996. High rate of indeterminate reactivity to HTLV in western blot analysis of Spanish blood donors. Vox Sang. 70:120-121.
28. Sowa, J. M. 1992. Human T lymphotropic virus I, myelopathy, polymyositis and synovitis: an expanding rheumatic spectrum. J. Rheumatol. 19:316-318.
29. Vrielink, H., H. L. Zaaijer, H. T. M. Cuypers, C. L. van der Poel, M. Woerdeman, P. N. Lelie, C. Winkel, and H. W. Reesnik. 1997. Evaluation of a new HTLV-I/II polymerase chain reaction. Vox Sang. 72:144-147.
30. Washitani, Y., N. Kuroda, H. Shiraki, Y. Nishimura, K. Yamaguchi, K. Takatsuki, L. P. Fernando, C. T. Fang, H. Kiyokawa, and Y. Maeda. 1991. Serological discrimination between HTLV-I and HTLV-II antibodies by ELISA using synthetic peptides as antigens. Int. J. Cancer 49:173-177.
31. Wu, E., D. W. Dickson, S. Jacobson, and C. S. Raine. 1993. Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations. Acta Neuropathol. Berlin 86:224-235.
32. Yamashita, K., M. Maekawa, K. Mitani, M. Wakamiya, T. Ogino, K. Miyamura, K. Baba, Y. Yamamoto, H. Nyunoya, K. Shimotohno, et al. 1992. Evaluation of enzyme immunoassay using a recombinant envelope protein expressed in insect cells for serological confirmation of HTLV-I infection. AIDS Res. Hum. Retroviruses 8:1857-1861.